GO:0055006 cardiac cell development: Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055006 cardiac cell development describes the progression of a cardiac cell from its formation to its mature state.
• Cardiac cell development encompasses cardiomyocyte specification, proliferation, differentiation, maturation, and structural organization.
• Single-cell and spatial transcriptomics have resolved cardiac cell development into distinct lineage trajectories and maturation states.
• Endothelial-to-mesenchymal transition (EndoMT) contributes to cardiac cell diversity during development.
• Human pluripotent stem cell-derived cardiac tissues can be matured to advanced stages, enabling developmental studies.
• Cardiac stem cell niches provide microenvironments that regulate cardiac cell development and homeostasis.
Description
Cardiac cell development (GO:0055006) is the biological process by which a cardiac cell progresses over time from its formation to the mature state. This term encompasses the specification of cardiac progenitors, their proliferation and differentiation into cardiomyocytes and other cardiac cell types, and the structural and functional maturation that enables coordinated heart contraction. Understanding this process is fundamental to developmental biology and regenerative medicine, as disruptions in cardiac cell development underlie congenital heart defects and contribute to heart failure. Recent advances in single-cell resolution have provided unprecedented insights into the molecular mechanisms and lineage relationships governing cardiac cell development. The process involves complex gene regulatory networks, signaling pathways, and cell-cell interactions that orchestrate the formation of a functional heart.
cardiac cell development At A Glance
| GO ID | GO:0055006 |
|---|---|
| GO term | cardiac cell development |
| Ontology | biological_process |
| Synonym | cardiocyte development, heart cell development |
| Major function | Progression of a cardiac cell from formation to mature state |
| Related processes | Cardiac myocyte cell cycle control, endothelial-to-mesenchymal transition, cardiac maturation |
| Key cell types | Cardiomyocytes, cardiac progenitors, endothelial cells, fibroblasts |
| Research relevance | Congenital heart defects, regenerative medicine, cardiac tissue engineering |
What Is GO:0055006?
According to the Gene Ontology, cardiac cell development (GO:0055006) is defined as the process whose specific outcome is the progression of a cardiac cell over time, from its formation to the mature state. A cardiac cell is a cell that will form part of the cardiac organ of an individual. This biological process includes the initial specification of cardiac progenitors, their proliferation, differentiation into specialized cardiac cell types such as cardiomyocytes, and the subsequent maturation steps that establish mature cardiac cell structure and function.
Why Is cardiac cell development Important in Cell Biology?
Cardiac cell development is critically important because it provides the foundation for understanding how the heart forms and functions, and how disruptions in these processes lead to congenital heart defects and acquired cardiac diseases. The precise regulation of cardiac cell proliferation, differentiation, and maturation is essential for producing the correct number and types of cardiac cells during embryogenesis. Moreover, insights into cardiac cell development inform regenerative strategies aimed at repairing damaged myocardium, as the adult heart has limited regenerative capacity. Single-cell technologies have revealed that cardiac cell development involves heterogeneous cell populations and dynamic transcriptional programs that are essential for proper heart formation.
• Defects in cardiac cell development cause congenital heart defects, the most common birth defects.
• Cardiac myocyte cell cycle control during development is distinct from that in disease and regeneration.
• Endothelial-to-mesenchymal transition contributes to cardiac valve formation and cardiac cell diversity.
• Single-cell resolution reveals lineage trajectories and maturation states of cardiac cells.
• Human pluripotent stem cell-derived cardiac tissues can be matured for developmental modeling.
• Cardiac stem cell niches regulate cardiac cell homeostasis and repair.
• Understanding cardiac cell development aids in designing regenerative therapies for heart failure.
• Zebrafish and other model organisms provide conserved insights into cardiac development.
• Spatial transcriptomics links cardiac cell development to tissue architecture.
• Dysregulation of cardiac cell development is implicated in cardiomyopathies and arrhythmias.
What Happens During cardiac cell development?
Cardiac progenitor specification and proliferation
In simple terms: Early embryonic cells are instructed to become heart cells and multiply.
Cardiac cell development begins with the specification of cardiac progenitors from mesodermal lineages, driven by a network of transcription factors and signaling molecules. These progenitors proliferate to expand the pool of cardiac cells, a process tightly regulated by cell cycle machinery. Single-cell studies have identified distinct progenitor populations and their transcriptional trajectories during early heart formation.
Differentiation into cardiomyocytes and other cardiac cell types
In simple terms: Progenitor cells specialize into the various cell types that make up the heart.
Cardiac progenitors differentiate into cardiomyocytes, endothelial cells, smooth muscle cells, and fibroblasts, a process governed by lineage-specific transcription factors and signaling pathways. Endothelial-to-mesenchymal transition (EndoMT) is a key mechanism generating cardiac valve cells and contributing to cardiac cell diversity. The differentiation process is accompanied by exit from the cell cycle and expression of cardiac-specific structural proteins.
Cardiomyocyte maturation and structural organization
In simple terms: Heart muscle cells grow, organize their internal structures, and become fully functional.
Following differentiation, cardiomyocytes undergo maturation characterized by sarcomere assembly, increased cell size, and metabolic switching. Advanced maturation of human cardiac tissue grown from pluripotent stem cells can be achieved through specific culture conditions, enabling studies of developmental maturation. Spatial transcriptomics has revealed that cardiac cell maturation is spatially organized within the developing heart.
Cardiac stem cell niches and postnatal development
In simple terms: Specialized microenvironments support heart cell development and maintenance after birth.
Cardiac stem cell niches provide signals that regulate cardiac cell development and homeostasis, and their dysfunction contributes to disease. Postnatal cardiac development involves further growth and maturation of cardiomyocytes, although the capacity for proliferation declines after birth. Understanding niche regulation is important for regenerative approaches.
Key Genes Involved in GO:0055006 cardiac cell development
Key genes and proteins involved in cardiac cell development include transcription factors, signaling molecules, and structural components that orchestrate cardiac cell specification, differentiation, and maturation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NKX2-5 | Cardiac transcription factor essential for heart development | Mutations cause congenital heart defects; key marker of cardiac progenitors |
| GATA4 | Transcription factor regulating cardiac gene expression | Critical for cardiomyocyte differentiation; mutations linked to septal defects |
| TBX5 | Transcription factor involved in cardiac lineage specification | Mutations cause Holt-Oram syndrome; regulates cardiac cell development |
| MEF2C | Transcription factor promoting cardiomyocyte differentiation | Essential for sarcomere organization and cardiac maturation |
| MYH6 | Cardiac myosin heavy chain | Structural component of sarcomeres; marker of mature cardiomyocytes |
| MYH7 | Cardiac myosin heavy chain beta | Expressed in developing and adult heart; mutations cause cardiomyopathy |
| TNNT2 | Cardiac troponin T | Regulates cardiac muscle contraction; marker of cardiomyocyte maturation |
| ACTC1 | Cardiac actin | Essential for sarcomere formation; mutations linked to heart disease |
| CDH5 | Vascular endothelial cadherin | Marker of endothelial cells; involved in EndoMT |
| VIM | Vimentin | Mesenchymal marker upregulated during EndoMT |
| PECAM1 | Platelet endothelial cell adhesion molecule | Endothelial marker; used to identify cardiac endothelial cells |
| KDR | VEGF receptor 2 | Markers of cardiac progenitors; regulates proliferation |
| ISL1 | Transcription factor in cardiac progenitors | Regulates progenitor proliferation and differentiation |
| HAND1 | Transcription factor in cardiac development | Essential for ventricular chamber formation |
| HAND2 | Transcription factor in cardiac development | Regulates cardiac morphogenesis and differentiation |
| SRF | Serum response factor | Regulates cardiac gene expression and sarcomere assembly |
| MYOCD | Myocardin | Coactivator of SRF; promotes smooth muscle and cardiac gene expression |
How Is cardiac cell development Regulated?
Cardiac cell development is regulated by a complex interplay of transcription factors, signaling pathways, and epigenetic modifiers. Key signaling pathways include Wnt, Notch, BMP, and FGF, which control progenitor specification, proliferation, and differentiation. Cell cycle regulators govern the balance between proliferation and differentiation of cardiac cells. Endothelial-to-mesenchymal transition is regulated by TGF-beta and BMP signaling, which are critical for cardiac valve development. Additionally, cardiac stem cell niches provide local signals that modulate cardiac cell development and repair. Single-cell studies have revealed dynamic changes in gene regulatory networks during cardiac cell development.
cardiac cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NKX2-5 | Congenital heart defects, septal defects | Knockout and point-mutation models in human iPSCs and mouse |
| GATA4 | Congenital heart defects, cardiomyopathy | Knock-in of patient mutations in iPSC-derived cardiomyocytes |
| TBX5 | Holt-Oram syndrome, cardiac malformations | Knockout and overexpression in zebrafish and mouse |
| MYH7 | Hypertrophic cardiomyopathy | Point-mutation knock-in in iPSCs and mouse |
| TNNT2 | Dilated cardiomyopathy | Knock-in of mutations in human iPSC-derived cardiomyocytes |
Congenital heart defects
Disruptions in cardiac cell development are a major cause of congenital heart defects, including septal defects, valve malformations, and chamber abnormalities. Mutations in cardiac transcription factors such as NKX2-5, GATA4, and TBX5 impair cardiac cell specification and differentiation, leading to structural heart defects. EndoMT defects contribute to valve and septal defects.
Cardiomyopathies and heart failure
Abnormal cardiac cell development and maturation can lead to cardiomyopathies, characterized by impaired contractility and structural remodeling. Mutations in sarcomeric genes such as MYH7 and TNNT2 affect cardiomyocyte maturation and function, contributing to hypertrophic and dilated cardiomyopathies. Understanding developmental pathways may inform regenerative therapies for heart failure.
Arrhythmias
Defects in cardiac cell development can disrupt electrical conduction systems, leading to arrhythmias. Proper maturation of cardiomyocytes is essential for establishing normal electrical properties, and developmental abnormalities may predispose to arrhythmogenic conditions.
From cardiac cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of a transcription factor in cardiac progenitor specification | Knockout of the gene in human iPSCs followed by cardiac differentiation |
| Effect of a point mutation on cardiomyocyte maturation | Point-mutation knock-in in iPSCs and assessment of sarcomere structure |
| Contribution of a gene to EndoMT | Knockout or overexpression in endothelial cells and EndoMT assays |
| Lineage tracing of cardiac progenitors | Knock-in of reporter genes (e.g., fluorescent proteins) in model organisms |
| Rescue of a developmental defect by gene overexpression | Overexpression of wild-type gene in mutant background |
| High-throughput screening of cardiac development regulators | CRISPR library screening in iPSC-derived cardiac cells |
How to Study the cardiac cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptional profiles of individual cells | Identifying cardiac cell types and developmental trajectories |
| Spatial transcriptomics | Gene expression with spatial context | Mapping cardiac cell development in tissue architecture |
| CRISPR knockout screening | Gene function by loss-of-function | Discovering regulators of cardiac differentiation |
| CRISPR activation screening | Gene function by gain-of-function | Identifying enhancers and activators of cardiac development |
| Immunofluorescence | Protein localization and expression | Assessing sarcomere assembly and cardiac markers |
| Electrophysiology | Electrical activity of cardiomyocytes | Evaluating maturation and arrhythmia potential |
| Proteomics | Protein abundance and modifications | Characterizing cardiac cell maturation states |
| Lineage tracing | Cell fate and origin | Tracking cardiac progenitor contributions |
Single-cell transcriptomics
Single-cell RNA sequencing has revolutionized the study of cardiac cell development by resolving cellular heterogeneity and lineage trajectories. This method identifies distinct cardiac cell populations and their developmental states, revealing dynamic gene expression programs. Spatial transcriptomics further adds spatial context to these developmental processes.
CRISPR-based genetic screens
CRISPR knockout and activation screens enable systematic interrogation of gene function in cardiac cell development. Pooled screens can identify regulators of cardiomyocyte differentiation and maturation, providing insights into developmental mechanisms.
Human pluripotent stem cell models
Human pluripotent stem cells can be differentiated into cardiac cells and matured to advanced stages, providing a platform to study cardiac cell development. These models allow genetic manipulation and functional assessment of candidate genes.
Imaging and functional assays
Live-cell imaging, immunofluorescence, and electrophysiology are used to assess cardiac cell morphology, sarcomere organization, and contractility during development. These methods complement molecular profiling to provide a comprehensive view of cardiac cell development.
How CRISPR Can Be Used to Study GO:0055006 cardiac cell development
Knockout
CRISPR knockout is used to ablate candidate genes in human iPSCs or model organisms to determine their requirement for cardiac cell development. For example, knockout of NKX2-5 or GATA4 impairs cardiac differentiation and reveals essential roles in cardiac cell specification.
Point Mutation
CRISPR point mutation introduces specific disease-associated mutations to model their effects on cardiac cell development. This approach is valuable for studying sarcomeric gene mutations that cause cardiomyopathies and affect cardiomyocyte maturation.
Knock-in
CRISPR knock-in enables precise insertion of reporter genes, tags, or human disease alleles into endogenous loci. This allows lineage tracing of cardiac progenitors and functional analysis of cardiac genes in their native context.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression is used to upregulate genes of interest to assess sufficiency in promoting cardiac cell development. Overexpression of transcription factors such as MYOCD or GATA4 can enhance cardiac differentiation.
How EDITGENE Supports cardiac cell development Research
Researchers studying cardiac cell development-related genes often need to determine whether a candidate gene is causally involved in cardiac progenitor specification, differentiation, or maturation. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies in cardiac cell development.
Contact EDITGENE today to design your custom CRISPR model for cardiac cell development research.
Frequently Asked Questions About cardiac cell development
What is cardiac cell development?
Cardiac cell development (GO:0055006) is the biological process by which a cardiac cell progresses from its formation to the mature state, encompassing specification, proliferation, differentiation, and maturation.
What genes are involved in cardiac cell development?
Key genes include NKX2-5, GATA4, TBX5, MEF2C, MYH6, MYH7, TNNT2, and ACTC1, among others.
What are the stages of cardiac cell development?
Stages include cardiac progenitor specification, proliferation, differentiation into cardiomyocytes and other cell types, and maturation.
How is cardiac cell development studied?
It is studied using single-cell transcriptomics, CRISPR screens, human pluripotent stem cell models, imaging, and functional assays.
What diseases are linked to defects in cardiac cell development?
Congenital heart defects, cardiomyopathies, and arrhythmias are linked to disrupted cardiac cell development.
What is the role of EndoMT in cardiac cell development?
Endothelial-to-mesenchymal transition contributes to cardiac valve formation and generates diverse cardiac cell types.
Can cardiac cell development be modeled in vitro?
Yes, human pluripotent stem cells can be differentiated into cardiac cells and matured to advanced stages for developmental studies.
What is the role of cardiac stem cell niches?
Cardiac stem cell niches provide microenvironments that regulate cardiac cell development, homeostasis, and repair.
How does single-cell technology advance cardiac development research?
Single-cell and spatial transcriptomics resolve cellular heterogeneity and lineage trajectories during cardiac cell development.
What model organisms are used to study cardiac cell development?
Zebrafish, mouse, and other model organisms are widely used due to conserved developmental mechanisms.
Conclusion
Cardiac cell development (GO:0055006) is a fundamental biological process that governs the formation and maturation of cardiac cells, with critical implications for congenital heart defects and regenerative medicine. Advances in single-cell technologies and CRISPR-based models have provided unprecedented insights into the molecular mechanisms and lineage relationships underlying this process. Continued research into cardiac cell development will inform novel therapeutic strategies for heart disease and tissue regeneration.
References
- 1. Wei N et al.. 2024. Cardiac Development at a Single-Cell Resolution.. Adv Exp Med Biol 1441:253-268 PMID: 38884716
- 2. Li Y et al.. 2024. The molecular mechanisms of cardiac development and related diseases.. Signal Transduct Target Ther 9(1):368 PMID: 39715759
- 3. Ahuja P et al.. 2007. Cardiac myocyte cell cycle control in development, disease, and regeneration.. Physiol Rev 87(2):521-44 PMID: 17429040
- 4. Bischoff J. 2019. Endothelial-to-Mesenchymal Transition.. Circ Res 124(8):1163-1165 PMID: 30973806
- 5. Li B et al.. 2026. Decoding Cardiac Development and Maturation at Single-Cell and Spatial Transcriptomic Resolution.. Circ Res 139(4):e327473 PMID: 42531359
- 6. Ronaldson-Bouchard K et al.. 2018. Advanced maturation of human cardiac tissue grown from pluripotent stem cells.. Nature 556(7700):239-243 PMID: 29618819
- 7. Leri A et al.. 2014. Cardiac stem cell niches.. Stem Cell Res 13(3 Pt B):631-46 PMID: 25267073
- 8. Trinh LA et al.. 2004. Cardiac development.. Methods Cell Biol 76:455-73 PMID: 15602887
